CIK 0000818686 · Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972 (3) 914-8213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,242,786
- in 10 filings, $10.6M under 10b5-1 plans
Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-04 | Daniell Richard Exec. VP, European Commercial | Option exercise · Restricted Share Units | −15,920 | 15,921 | ||
| 2022-03-04 | Daniell Richard Exec. VP, European Commercial | Option exercise · Restricted Share Units | −43,358 | 0 | ||
| 2022-03-04 | Daniell Richard Exec. VP, European Commercial | Grant or award · Restricted Share Units | +134,048 | 134,048 | ||
| 2022-03-02 | Weiss Amir Chief Accounting Officer | Option exercise | +981 | 18,591.41 | ||
| 2022-03-02 | Weiss Amir Chief Accounting Officer | Option exercise · Restricted Share Units | −981 | 0 | ||
| 2022-02-28 | Weiss Amir Chief Accounting Officer | Option exercise | +3,219 | 17,610.41 | ||
| 2022-02-28 | Weiss Amir Chief Accounting Officer | Option exercise · Restricted Share Units | −3,219 | 6,438 | ||
| 2022-02-28 | Stark David Matthew Exec. VP Chief Legal Officer | Option exercise | +18,430 | 27,832.39 | ||
| 2022-02-28 | Stark David Matthew Exec. VP Chief Legal Officer | Sale | −6,452 | $8.14 | $53K | 21,380.39 |
| 2022-02-28 | Stark David Matthew Exec. VP Chief Legal Officer | Option exercise · Restricted Share Units | −18,430 | 36,860 | ||
| 2022-02-28 | Shani Eli EVP,Global Marketing&Portfolio | Option exercise | +5,311 | 14,402 | ||
| 2022-02-28 | Shani Eli EVP,Global Marketing&Portfolio | Sale | −5,311 | $8.14 | $43K | 9,091 |
| 2022-02-28 | Shani Eli EVP,Global Marketing&Portfolio | Option exercise · Restricted Share Units | −5,311 | 10,623 | ||
| 2022-02-28 | Schultz Kare President and CEO | Option exercise | +65,047 | 1,132,496 | ||
| 2022-02-28 | Schultz Kare President and CEO | Option exercise · Restricted Share Units | −65,047 | 130,096 | ||
| 2022-02-28 | Sabag Mark EVP, International Markets | Option exercise | +20,598 | 94,603 | ||
| 2022-02-28 | Sabag Mark EVP, International Markets | Option exercise · Restricted Share Units | −20,598 | 41,197 | ||
| 2022-02-28 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Option exercise | +18,430 | 43,489 | ||
| 2022-02-28 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Option exercise · Restricted Share Units | −18,430 | 36,860 | ||
| 2022-02-28 | Inbar Galia See "Remarks" | Option exercise | +4,828 | 9,656 |
Page 40 of 76 · 1,517 trades